Clinical trial
Donepezil in the Prevention of Post-Operative Cognitive Decline
NCT00182845 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00182845 |
|---|---|
| Title | Donepezil in the Prevention of Post-Operative Cognitive Decline |
| Official title | Preventing Post-Operative Cognitive Decline |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Postoperative Complications, Delirium |
| Intervention type | Drug |
| Interventions | Donepezil |
| Enrollment | 30 |
| Start date | Feb 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: